SpringWorks Therapeutics (SWTX) Event Aug. 04, 2022, 00:00 UTC (75% Positive) SPRINGWORKS THERAPEUTICS, INC. (SWTX) Reports 41% Loss Reduction for 2022-06-30 Full text
Register to leave comments News bot Oct. 29, 2025, 10:51 a.m. 🏢 SpringWorks Therapeutics (SWTX) - Form 10-Q Quarterly Report Quarterly financial filing submitted to the SEC 📋 Filing Information 📄 Form Type: 10-Q 📅 Filing Date: 2022-08-04 📊 Period of Report: 2022-06-30 ⏰ Accepted: N/A 📊 Key Financial Metrics (Period-over-Period Comparison) Metric Current Period Previous Period Change ($) Change (%) Trend Net Income/Loss $-76.80M $-130.85M $54.05M +41.31% 📉 Total Assets $452.49M $365.92M $86.58M +23.66% 📈 Total Liabilities $30.10M $40.19M $-10.09M -25.10% 📈 Stockholders' Equity $325.73M $-423.36M $749.10M +176.94% 📈 Operating Income/Loss $-76.78M $-130.48M $53.70M +41.16% 📉 R&D Expense $49.47M $72.13M $-22.66M -31.42% 📈 📈 Financial Trend Analysis 🔻 Reported net loss for the period • 🏦 Strengthened balance sheet with assets growing faster than liabilities 📎 View Full 10-Q Filing on SEC.gov Access the complete official filing document
🏢 SpringWorks Therapeutics (SWTX) - Form 10-Q Quarterly Report
📋 Filing Information
Key Financial Metrics (Period-over-Period Comparison)
Financial Trend Analysis
🔻 Reported net loss for the period • 🏦 Strengthened balance sheet with assets growing faster than liabilities
📎 View Full 10-Q Filing on SEC.gov
Access the complete official filing document